EUVIMEDDescobrir EUVIMED
Open access · CC BY-NC-ND 4.0

Reactivation of methylation‐silenced PAX1 inhibits cervical cancer proliferation and migration via the WNT/TIMELESS pathway

Wenfan Zhang, Huixi Wang, Shuang Chen, Xueting Fan, Yuqing Liu, Shujuan Shi, Rong Wang iD

Molecular Carcinogenesis · 2024

DOI: 10.1002/mc.23728 ↗

At a glance

Journal article in Molecular Carcinogenesis, 2024. Written by Wenfan Zhang and 6 co-authors. Institution: Department of Laboratory Medicine, School of Tianjin Medical Technology, Tianjin Medical University, Tianjin, China. Major MEDLINE topics: Cell Proliferation, DNA Methylation, Gene Expression Regulation, Neoplastic, Uterine Cervical Neoplasms. Cited 10 times so far (Crossref); 41 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: National Natural Science Foundation of China.

ResumoSubjectsDados bibliográficosCiteRelated studies

Abstract (original language)

Although aberrant methylation of PAX1 is closely associated with cervical cancer (CC), PAX1 methylation (PAX1m) and its role in CC remain to be elucidated. Here, we clarified the biological function of PAX1 in CC. First, PAX1m in ThinPrep cytologic test samples was measured via quantitative methylation‐specific PCR. The results showed that PAX1 promoter methylation levels were significantly increased in CC patients ( p < 0.001). We also found that PAX1 promoter methylation levels were positively correlated with tumor purity but negatively correlated with immune‐infiltration via public databases. Then, CRISPR‐based methylation perturbation tools (dCas9‐Tet1) were constructed to further demonstrate that DNA methylation participates in the regulation of PAX1 expression directly. Gain‐ and loss‐of‐function experiments were used to show that PAX1 overexpression restrained proliferation, migration and improved cisplatin sensitivity by interfering with the WNT/TIMELESS axis in CC cells. Additionally, Co‐immunoprecipitation assays further confirmed the interaction between PAX1 and TCF7L2. Taken together, our results suggested that a tumor suppressor role of PAX1 in CC and that CRISPR‐based PAX1 demethylation editing might be a promising therapeutic strategy for CC.

Subjects

MeSH terms (MEDLINE)

Cell ProliferationDNA MethylationGene Expression Regulation, NeoplasticUterine Cervical NeoplasmsWnt Signaling PathwayFemaleHumansCell Line, TumorCell MovementPaired Box Transcription FactorsPromoter Regions, Genetic

Author keywords

CRISPR‐dCas9‐Tet1DNA methylationPAX1WNT/TIMELESScervical cancer

Substances

Paired Box Transcription FactorsPAX1 transcription factor

Authors and institutions

  • Department of Laboratory Medicine, School of Tianjin Medical Technology, Tianjin Medical University, Tianjin, China.
  • Department of Human Anatomy, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.

ORCID profiles: Rong Wang

Funding

  • National Natural Science Foundation of China

Cite

APA

Zhang, W., Wang, H., Chen, S., Fan, X., Liu, Y., Shi, S., & Wang, R. (2024). Reactivation of methylation‐silenced PAX1 inhibits cervical cancer proliferation and migration via the WNT/TIMELESS pathway. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23728

Vancouver

Zhang W, Wang H, Chen S, Fan X, Liu Y, Shi S, et al. Reactivation of methylation‐silenced PAX1 inhibits cervical cancer proliferation and migration via the WNT/TIMELESS pathway. Molecular Carcinogenesis. 2024. doi:10.1002/mc.23728

BibTeX
@article{Zhang2024,
  author = {Zhang, Wenfan and Wang, Huixi and Chen, Shuang and Fan, Xueting and Liu, Yuqing and Shi, Shujuan and Wang, Rong},
  title = {Reactivation of methylation‐silenced PAX1 inhibits cervical cancer proliferation and migration via the WNT/TIMELESS pathway},
  journal = {Molecular Carcinogenesis},
  year = {2024},
  doi = {10.1002/mc.23728}
}
Start for free →